`
`
`
`
`
`
`
`
`
`
`米国特許商標局
`AA LB er aA
`
`eT2S Hl SH BRO AC
`特許公判審判部の面前で
`
`
`
`アクルックス DDS PTY 社及びアクルックス社
`FV IIVYZA DDS PTY £ RUPPFILA
`申立人、
`FA WA,
`
` 対
`
`
`
`xf
`
`科研製薬株式会社、及び
`FiLRT SAL, BU
`バリアント製薬インターナショナル社
`INPVERRYS—tvat vet
`特許権者及び実施権者
`FiteAaRURMES
`
`
`
`件: IPR2017-00190
`4+: IPR2017-00190
`米国特許第 7,214,506
`HE FEES 7,214,506
`
`
`
`宮川基則の証拠物件に関わる宣言書
`HNlSUOTMMFBDOae
`
`
`
`
`
`
`
`
`Page | of 3
`
`Kaken Exhibit 2113
`Acrux v. Kaken
`IPR2017-00190
`
`
`
`fh. BRIE, Pate CCIMETS :
`
`1.
`
`lt, BR RRRSH (A) (ICKY RDNTWS. BEOMMLATO
`
`RSSSRSTVIVAL y—CHY, 1996 FURMILAICH
`
`BLCEELK. ABSECHNSNT SSAC SMILED BSOMRMEALTH
`
`UY. EAC L COMBA EC SONEBAISIA, CLCBBLCWSCEEMRICEELY
`
`ELETF,
`
`2.
`
`ld, RETCHIFVEy R200 EL THM ENKEBRL CN SERORE
`
`W4ECT. CIVEY bh 2095 1k 2014 FAH 2017 FEOMMICBSRET—2—-—E
`
`MI HHHCHS. Blt, IMS Health OF—2—NA—Z GAA FVE y b 2110)
`
`D © Rea iw CT 2017 FE 2016 FIC KM EHKET—2—-DSOA COMBAITO—-E&
`
`ELt, RHREFRMLELK. EOF—-3—-KA—AILFROBMBRORY LIED
`
`7A—F SAI PIMIXH>o TH SEOCHS,. Bld, Ek. COHOBMICBDSH
`
`COCKE RBILRS Sa RSOIBBIC OUTIL, MRALALTHET, EOR
`
`7% IMS Health ®5O7—28—-2AFL, FHL. TATVEy 2095 OHRGRHRE
`
`sARMICHOS CLISER CHV), POND COMBZORBO—-MCLE.
`
`3.
`
`{FV Yb 2095 (LHHOD $1 ILAORHROLHRAOEES ES LCEHS
`
`CEOS CHILES 4.
`
`4.0
`
`BIS, (FVEY 2095CHMENTISIAMIS FHOBY CHSTCERC
`
`— GEERT 4.
`
`Page 2 of 3
`
`
`
`(A) Chto OCHRE TUS BHO YES L CIS EOICAAIC A Y Heme
`
`WILLD CHSCEECHSICMUTHILMBE AT SBACHY,
`
`(B) CHI<AMAIC BS SHMARH, HAT SREMY-ERERHTS,.
`
`ORBITAL CMREAT S IMS Health 5 AFL (tH ERIC L CHE
`MENEEDCHY, RU
`
`(C) HID BOWMAN 2 TUB ORBO-RE LTREENTULEOTH
`
`bce,
`
`COOSTORES, MABPASMMSCLICKS<( BECHY, STOMMLES
`
`CROW CHbNSRELBECHSLIECSLOCHY, BIC, HES. BRHG
`
`4 ORE SE EOREL OSS REAERS 18HOR 1001 KL, MSS < (LB,
`
`Rshsc¢PROMSHL SNS CEMHVISBSCLERMLELTC CIMA ES
`
`bo
`DATE: &) 2 2, 2017
`
`4 .
`~
`/y
`By:__Z
`Motonori Miyakawa
`
`Page 3 of 3
`
`